Compass Therapeutics, Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 0.7698 USD (Oct 30, 2026, 3:19 PM EDT) · Market cap 138.63M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, develops antibody-based therapeutics for the treatment of various human diseases in the United States. The company’s lead product candidate, tovecimig, is a bispecific antibody that targets delta-like ligand 4 (DLL4) and vascular endothelial growth factor A (VEGF-A), which are critical to angiogenesis and tumor vascularization. It also develops CTX-471, an IgG4 monoclonal antibody that is an agonist of CD137, a key co-stimulatory receptor on immune cells; CTX-8371, a bispecific inhibitor that targets programmed cell death protein-1 (PD-1) and ligand PD-L1 checkpoint inhibitor antibodies; and CTX-10726, a bispecific antibody that targets PD-1 and VEFG-A. The company was founded in 2014 and is headquartered in Boston, Massachusetts.
Details
| Name | Compass Therapeutics, Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 39 |
| Founded | 2014 |
| Ceo | Thomas Schuetz |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | US20454B1044 |
| Cusip | 20454B104 |
| Cik | 1738021 |
| Sic | 2836 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Dr. Thomas J. Schuetz M.D., Ph.D. | Chief Executive Officer and Vice Chairman |
| Barry Shin J.D., M.B.A. | Chief Financial Officer |
| Jonathan E. Anderman J.D. | Senior Vice President, General Counsel and Corporate Secretary |
| Neil L. Lerner CPA | Senior Vice President and Chief Accounting Officer |
| Bing Gong Ph.D. | Chief Scientific Officer |
| Anna Gifford | Senior Manager of Communications and Chief of Staff |
| Karin Herrera B.A. | Senior Vice President and Head of Clinical Operations |
| Dr. James Kranz Ph.D. | Vice President and Head of Chemistry Manufacturing and Controls |
| Dr. Cynthia A. Sirard M.D., Ph.D. | Chief Medical Officer |
| Arjun Prasad M.B.A., M.P.H. | Chief Commercial Officer |
Contact
| Address | 80 Guest Street, Suite 601, Boston, Massachusetts 02135, United States |
| Phone | 617 500 8099 |
| Website | https://www.compasstherapeutics.com |